DOCSLIB.ORG

Surveillance of Drug Abuse Trends in the State of Ohio (OSAM)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Surveillance of Drug Abuse Trends in the State of Ohio (OSAM) Ohio Substance Abuse Monitoring Network Surveillance of Drug Abuse Trends in the State of Ohio June 2011-January 2012 John R. Kasich, Governor Orman Hall, Director LUCAS LAKE ASHTABULA WILLIAMS FULTON OTTAWA GEAUGA WOOD CUYAHOGA DEFIANCE HENRY SANDUSKY ERIE TRUMBULLTRU LORAIN HURON PAULDING SENECA MEDINA SUMMIT PORTAGE PUTNAM HANCOCK AHONINGAH VAN WERT YYANDOTANDOT ASHLAASHLA WAYNE LUMBIANALU CRAWFORD STARK RICHLAND ALLEN CARROLL HARDIN MERCER MARION OLMES MORROW AUGLAIZE TUSCARAWAS ON FFERS KNOX LOGAN SHELBY UNION DELAWARE COSHOCTON HARRISON CHAMPAIGN DARKE LICKING MIAMI FRANKLIN GUERNSEY BELMONT CLARK USKINGUM DISON MA PREBLE MONTGOMERY FAIRFIELD NOBLE GREENE MONROE PICKAWAY MORGAN FAYETTE WASHINGTON BUTLER WARREN CLINTON ATHENS ROSS VINTON HAMILTON HIGHLAND MEIGS PIKE CLERMONT JACKSON BROWN GALLIA ADAMS SCIOTO LAWRENCE Legend Akron-Canton region Columbus region Department of Alcohol & Athens region Dayton region Drug Addiction Services Cincinnati region Toledo region Cleveland region Youngstown region • Ohio Department of Alcohol and Drug Addiction Services • Division of Planning, Outcomes & Research • • 30 W. Spring St., 6th Floor, Columbus, Ohio 43215 • 1-800-788-7254 • www.odadas.ohio.gov • Surveillance of Drug Abuse Trends in the State of Ohio Table of Contents OSAM-O-Gram ..............................................................................................................................................................................1 Executive Summary ................................................................................................................................................................... 2 Drug Abuse Trends in the Akron-Canton Region ........................................................................................................... 9 Drug Abuse Trends in the Athens Region ........................................................................................................................28 Drug Abuse Trends in the Cincinnati Region ................................................................................................................. 48 Drug Abuse Trends in the Cleveland Region ................................................................................................................. 62 Drug Abuse Trends in the Columbus Region .................................................................................................................83 Drug Abuse Trends in the Dayton Region .......................................................................................................................97 Drug Abuse Trends in the Toledo Region ......................................................................................................................116 Drug Abuse Trends in the Youngstown Region ...........................................................................................................132 Prepared by: Ohio Department of Alcohol and Drug Addiction Services Division of Planning, Outcomes & Research Sanford Starr, Chief — MSW, LISW-S R. Thomas Sherba, OSAM Principal Investigator — PhD, MPH, LPCC Rick Massatti, Research Administrator, OSAM Coordinator — MSW Recommended citation of this report: Ohio Department of Alcohol and Drug Addiction Services [ODADAS] (2012). Ohio Substance Abuse Monitoring Network: Surveillance of Drug Abuse Trends in the State of Ohio: June 2011-January 2012. Ohio Substance Abuse Monitoring Network OSAM-O-GramOSAM-O-Gram Ohio Substance Abuse Monitoring Network Surveillance of Drug Abuse Trends in the State of Ohio June 2011-January 2012 John R. Kasich, Governor Orman Hall, Director Toledo Region Cleveland Region • Increased availability of heroin and Suboxone® likely • Increased availability of heroin, marijuana, methadone, methamphetamine • Most heroin users report first heroin use occurring between 18-19 years and sedave-hypnocs of age, with first use of prescripon opioids occurring earlier • Heroin availability perceived to be at “epidemic” levels • Dealers aggressively push heroin, frequently markeng it as fentanyl to • Increased availability of high-grade marijuana connues; marijuana is the lure more buyers most easily obtained illegal drug in the region • Connued availability of bath salts and synthec marijuana ancipated • Increased availability of methadone aributed to increased prescribing of despite recent bans the drug for pain management • Crime lab reports dozens of non-controlled chemical analogues similar to • DMT (dimethyltryptamine), a psychedelic compound popular among users bath salts 16-25 years of age is thought to be an emerging drug trend Dayton Region • Increased availability of heroin and Akron-Canton Region marijuana • Increased availability of heroin, • Decreased availability of bath salts powdered cocaine, sedave-hypnocs and prescripon opioids (generally) and Suboxone® • Universal agreement that heroin is • Decreased availability of available; it is “falling out of the sky” prescripon opioids (generally) • Methadone abuse increasingly • Opana® connues to gain in popular; Coroner’s staff reported popularity as a replacement for methadone as the second-leading OxyConn® drug in overdose deaths • Bath salts highly available; connued • While bath salts have decreased in high availability despite recent ban availability since their ban, they • Synthec benzodiazepines (Zan-X®) remain easily obtainable available in head shops CincinnaƟ Region Youngstown Region • Increased availability of heroin • Increased availability of heroin and • Decreased availability of marijuana methamphetamine likely • Increased availability of some • Law enforcement aribute prescripon opioids, mainly Opana® and methamphetamine decline to Roxicodone® increased scruny by pharmacies • Decreased availability of Ecstasy using MethCheck® • Law enforcement indenfied heroin as • Opana® and Roxicodone® gain in the region’s primary drug problem popularity as replacements for OxyConn® • While methamphetamine remains relavely rare in some parts of the • Heroin becoming prevalent for region, reportedly, the drug is highly users in non-urban areas available in Ashtabula County Columbus Region Athens Region • Decreased availability of methamphetamine and prescripon opioids (generally) • Increased availability of heroin and Suboxone® • Decline in availability of prescripon opioids aributed to closing of physicians’ • Decreased availability of bath salts offices known to liberally prescribe, and increased regulaon on pharmacies • Opana® connues to gain in popularity as a replacement for OxyConn® • Crime labs report heroin to be “typically preƩy pure,” and one noted, “Columbus has an abundant supply of black tar heroin” • Increased scruny in emergency rooms means that users are looking elsewhere to obtain prescripon opioids • Age of heroin iniaon appears to be decreasing; reportedly, first-me users are as young as 15 years and typically White • Crime lab reports dozens of non-controlled chemical analogues similar to bath salts • Bath salts remain of serious concern due to negave health consequences; users reported panic aacks and suicidal thoughts • Ohio Department of Alcohol and Drug Addiction Services • Division of Planning, Outcomes & Research • • 30 W. Spring St., 6th Floor, Columbus, Ohio 43215 • 1-800-788-7254 • www.odadas.ohio.gov • Surveillance of Drug Abuse Trends in the State of Ohio Executive Summary drug of choice, but rather a drug often used to enhance the effects of other drugs. The most common participant The Ohio Substance Abuse Monitoring (OSAM) Network quality score of powdered cocaine throughout regions consists of eight regional epidemiologists (REPIs) located varied from ‘4’ to ’10,’ with the most common score being ‘5’ in Akron-Canton, Athens, Cincinnati, Cleveland, Columbus, on a scale of ‘0’ (poor quality, “garbage”) to ‘10’ (high quality). Dayton, Toledo and Youngstown. The OSAM Network Participants throughout regions reported that the quality conducts focus groups and individual qualitative interviews of powdered cocaine has either remained the same or has with treatment providers, active and recovering drug users, decreased during the past six months, and participants and law enforcement officials, among others, to produce were unanimous in reporting that the quality of powdered epidemiological descriptions of local substance abuse cocaine continues to depend on the drug’s source. trends. Qualitative findings are supplemented with available Reportedly, some dealers adulterate powdered cocaine with statistical data such as coroner’s reports and crime laboratory various substances to increase profitability. Regional crime data. Mass media sources such as local newspapers are also labs most often continued to report levamisole (livestock monitored for information related to substance abuse trends. dewormer) as the most frequently identified cutting agent Once integrated, these valuable sources provide ODADAS for powdered cocaine. In addition, participants in Akron- with a real-time method of providing accurate epidemiologic Canton, Athens and Cleveland reported that bath salts descriptions that policy makers need to plan appropriate (synthetic compounds containing methylone, mephedrone prevention and intervention strategies. or MDPV) are also used as a cutting agent. Current street This Executive Summary presents findings from the OSAM jargon includes many names for powdered cocaine, with core scientific meeting held in Columbus, Ohio, on Jan. 31, the most common names being “blow,” “coke,” “girl,” “powder,” 2012.
Load more

Recommended publications
  • International Narcotics Control Strategy Report
    United States Department of State Bureau for International Narcotics and Law Enforcement Affairs International Narcotics Control Strategy Report Volume I Drug and Chemical Control March 2017 INCSR 2017 Volume 1 Table of Contents Table of Contents Common Abbreviations ............................................................................................................................. iii International Agreements .......................................................................................................................... v INTRODUCTION ........................................................................................................................................... 1 Policy and Program Developments ......................................................................................................... 17 Overview ................................................................................................................................................. 18 Methodology for U.S. Government Estimates of Illegal Drug Production ............................................... 24 (with dates ratified/acceded) ................................................................................................................... 30 USG Assistance ..................................................................................................................................... 36 International Training .............................................................................................................................
    [Show full text]
  • What Are the Treatments for Heroin Addiction?
    How is heroin linked to prescription drug abuse? See page 3. from the director: Research Report Series Heroin is a highly addictive opioid drug, and its use has repercussions that extend far beyond the individual user. The medical and social consequences of drug use—such as hepatitis, HIV/AIDS, fetal effects, crime, violence, and disruptions in family, workplace, and educational environments—have a devastating impact on society and cost billions of dollars each year. Although heroin use in the general population is rather low, the numbers of people starting to use heroin have been steadily rising since 2007.1 This may be due in part to a shift from abuse of prescription pain relievers to heroin as a readily available, cheaper alternative2-5 and the misperception that highly pure heroin is safer than less pure forms because it does not need to be injected. Like many other chronic diseases, addiction can be treated. Medications HEROIN are available to treat heroin addiction while reducing drug cravings and withdrawal symptoms, improving the odds of achieving abstinence. There are now a variety of medications that can be tailored to a person’s recovery needs while taking into account co-occurring What is heroin and health conditions. Medication combined with behavioral therapy is particularly how is it used? effective, offering hope to individuals who suffer from addiction and for those around them. eroin is an illegal, highly addictive drug processed from morphine, a naturally occurring substance extracted from the seed pod of certain varieties The National Institute on Drug Abuse (NIDA) has developed this publication to Hof poppy plants.
    [Show full text]
  • Preferred Drug List (PDL) OREGON HEALTH PLAN Trilliumohp.Com
    Preferred Drug List (PDL) OREGON HEALTH PLAN TrilliumOHP.com 1-877-600-5472 TTY: 711 MCA_EK16V5 Approved 01/01/2019 OHP-TRIL-17-195 Pharmacy Program Trillium Community Health Plan’s goal is to offer the right drug coverage to our members. We work with doctors and pharmacists to make sure we offer drugs used to treat many conditions and illnesses. Trillium covers prescription and some over the counter drugs when they are ordered by a licensed prescriber. The pharmacy program does not cover all drugs. Some drugs need our prior approval. Some have a limit on the amount of drug that can be given. Sometimes you must get Trillium’s prior approval. Even with approval, we will not pay if you are no longer on OHP or if the treatment isn’t covered by OHP. To be paid, the treatment must follow treatment guidelines. This might include step therapy, meaning trying less costly treatment options first. Medications newly approved by the FDA (Food and Drug Administration) require prior- approval until reviewed by our Pharmacy and Therapeutics Committee. Filling a Prescription You can have your prescriptions filled at a Trillium network pharmacy. At the pharmacy, you will need to give the pharmacist your prescription and your ID card. You can find a pharmacy that is in network by calling a Trillium Member Services Representative at 541-485-2155; Toll Free: 1-877-600-5472, or by using the Find a Provider tool on our website at https://providersearch.trilliumhealthplan.com. You do not have to pay for covered drugs. The Trillium preferred drug list has a large number of brand name and generic drugs on it.
    [Show full text]
  • Skin Manifestations of Illicit Drug Use Manifestações Cutâneas
    RevABDV81N4.qxd 12.08.06 13:10 Page 307 307 Educação Médica Continuada Manifestações cutâneas decorrentes do uso de drogas ilícitas Skin manifestations of illicit drug use Bernardo Gontijo 1 Flávia Vasques Bittencourt 2 Lívia Flávia Sebe Lourenço 3 Resumo: O uso e abuso de drogas ilícitas é um problema significativo e de abrangência mun- dial. A Organização das Nações Unidas estima que 5% da população mundial entre os 15 e 64 anos fazem uso de drogas pelo menos uma vez por ano (prevalência anual), sendo que meta- de destes usam regularmente, isto é, pelo menos uma vez por mês. Muitos dos eventos adver- sos das drogas ilícitas surgem na pele, o que torna fundamental que o dermatologista esteja familiarizado com essas alterações. Palavras-chave: Drogas ilícitas; Drogas ilícitas/história; Drogas ilícitas/efeitos adversos; Pele; Revisão Abstract: Illicit drug use and abuse is a major problem all over the world. The United Nations estimates that 5% of world population (aged 15-64 years) use illicit drugs at least once a year (annual prevalence) and half of them use drugs regularly, that is, at least once a month. Many adverse events of illicit drugs arise on the skin and therefore dermatologists should be aware of these changes. Keywords: Street drugs; Street drugs/history; Street drugs/adverse effects; Skin; Review HISTÓRICO Há mais de cinco mil anos na Mesopotâmia, minorar o sofrimento dos condenados. região onde hoje se situa o Iraque, os poderes cal- Provavelmente seja o ópio a droga nephente à qual mantes, soníferos e anestésicos do ópio (do latim Homero se referia como “o mais poderoso destrui- opium, através do grego opion, ‘seiva, suco’) já eram dor de mágoas”.1,2 conhecidos pelos sumérios.
    [Show full text]
  • Defining Clinical Issues Around Tolerance, Hyperalgesia, And
    ORIGINAL ARTICLE Defining clinical issues around tolerance, hyperalgesia, and addiction: A quantitative and qualitative outcome study of long-term opioid dosing in a chronic pain practice Jennifer P. Schneider, MD, PhD; Kenneth L. Kirsh, PhD ARTICLE INFO ABSTRACT Keywords: Treatment with opioid medications has grown over the past decades, but has been tolerance surrounded by some ongoing controversy and debate to whether it is causing more dependence opioids harm than good for patients. To this end, the field of pain management has suf- hyperalgesia fered from a lack of clarity about some basic definitions on concepts such as toler- long-term opioid therapy ance and hyperalgesia. Some characterize these issues as inevitable parts of opioid therapy while other schools of thought look at these issues as relatively rare occur- Article history: rences. Unfortunately, most of the rhetoric around these topics has occurred with Received 13 February 2010 very little in the realm of real world data. To this end, the authors have reviewed Received in revised form 26 July 2010; the charts of 197 patients treated by a pain specialist for at least 1 year to better 30 August 2010 Accepted 31 August 2010 illustrate whether notions of tolerance and hyperalgesia are common occurrences DOI:10.5055/jom.2010.0036 and, more importantly, whether they occur within any type of specified timeframe. A total of 197 patient charts were reviewed. The sample had an average age of 49.39 years (range ϭ 19-87 years; standard deviation [SD] ϭ 12.48) and com- prised 66 men (33.5 percent) and 131 women (66.5 percent).
    [Show full text]
  • Surveillance of Drug Abuse Trends in the State of Ohio January - June 2019
    OSAMOSAM OhioOhio Substance Substance Abuse Abuse Monitoring Monitoring Network Network SurveillanceSurveillance of of Drug Drug Abuse Abuse Trends Trends in the State of Ohio January - June 2019 Lake Ashtabula Fulton Lucas Williams Ottawa Geauga Cuyahoga Defiance Henry Wood Sandusky Erie Lorain Trumbull Huron Summit Portage Paulding Seneca Medina Putnam Hancock Mahoning Van Wert Wyandot Crawford Ashland Wayne Stark Columbiana Allen Richland Hardin Marion Mercer Auglaize Holmes Carroll Morrow Tuscarawas Jefferson Logan Knox Shelby Union Delaware Coshocton Harrison Champaign Darke Licking Miami Guernsey Belmont Franklin Muskingum Clark Madison Montgomery Preble Fairfield Perry Noble Monroe Greene Pickaway Fayette Morgan Hocking Washington Butler Warren Clinton Ross Athens Vinton Hamilton Highland Clermont Pike Meigs Jackson Brown Adams Scioto Gallia Lawrence Legend Akron-Canton region Columbus region Athens region Dayton region Cincinnati region Toledo region Cleveland region Youngstown region Ohio Substance Abuse Monitoring Network Surveillance of Drug Abuse Trends in the State of Ohio January - June 2019 Prepared by: Ohio Department of Mental Health and Addiction Services Office of Quality, Planning and Research R. Thomas Sherba, OSAM Principal Investigator — PhD, MPH, LPCC Sarah Balser, OSAM Coordinator — MPH, MSW, LSW, CHES Jessica Linley, OSAM Quantitative Data Analyst — PhD, MSW, LSW Table of Contents OSAM-O-Gram....................................................................................................................................................................3
    [Show full text]
  • Commonly Used Drugs
    Commonly Used Drugs Many drugs can alter a person’s thinking and judgment, and can lead to health risks, including addiction, drugged driving, infectious disease, and adverse effects on pregnancy. Information on commonly used drugs with the potential for misuse or addiction can be found here. For information about treatment options for substance use disorders, see NIDA’s Treatment pages. For drug use trends, see our Trends and Statistics page. For the most up-to-date slang terms, please see Slang Terms and Code Words: A Reference for Law Enforcement Personnel (DEA, PDF, 1MB). The following drugs are included in this resource: ➢ Alcohol ➢ Methamphetamine ➢ Ayahuasca ➢ Over-the-Counter Medicines--Dextromethorphan ➢ Central Nervous System Depressants (DXM) ➢ Cocaine ➢ Over-the-Counter Medicines--Loperamide ➢ DMT ➢ PCP ➢ GHB ➢ Prescription Opioids ➢ Hallucinogens ➢ Prescription Stimulants ➢ Heroin ➢ Psilocybin ➢ Inhalants ➢ Rohypnol® (Flunitrazepam) ➢ Ketamine ➢ Salvia ➢ Khat ➢ Steroids (Anabolic) ➢ Kratom ➢ Synthetic Cannabinoids ➢ LSD ➢ Synthetic Cathinones ("Bath Salts") ➢ Marijuana (Cannabis) ➢ Tobacco/Nicotine ➢ MDMA (Ecstasy/Molly) ➢ Mescaline (Peyote) **Drugs are classified into five distinct categories or schedules “depending upon the drug’s acceptable medical use and the drug’s abuse or dependency potential.” More information and the most up-to-date scheduling information can be found on the Drug Enforcement Administration’s website. June 2020 Alcohol People drink to socialize, celebrate, and relax. Alcohol often has a strong effect on people—and throughout history, people have struggled to understand and manage alcohol’s power. Why does alcohol cause people to act and feel differently? How much is too much? Why do some people become addicted while others do not? The National Institute on Alcohol Abuse and Alcoholism is researching the answers to these and many other questions about alcohol.
    [Show full text]
  • Recognizing Drug Use in Adolescents
    RecognizingRecognizingRecognizing DrugDrugDrug UseUseUse ininin AdolescentsAAdolescentsdolescents A Quick Guide for Caregivers and Adults 1 RecognizingRecognizing DrugDrug UseUse inin AdolescentsAdolescents A Quick Guide for Caregivers and Adults Concerned caregivers and adults play an important role in ensuring that youth receive adequate help. However, at times it is hard to tell that youth are developing a problem with alcohol and drugs. This guide summarizes the signs of intoxication, use, and abuse commonly reported by substance users. It is important to recognize, however, that some of the behaviors and experiences described in this booklet may also be present among adolescents who are not using substances. For this reason, when deciding on the best course of action to obtain help for your teenager, make sure to talk with your teenager, gather as much information as possible, and consult with health professionals available in your community. i Alcohol and drug use poses significant risks for the healthy development of adolescents, yet substances of abuse are often readily accessible at school, at home, and in the community. This guide has been developed to facilitate early identification of substance use problems in youth. Included is information about common drugs of abuse and key information to help identify youth at risk. Recognizing the signs of use includes how a teenager might look, act, and feel while intoxicated as well as drug para- phernalia and language associated with each drug. g Signs of intoxication vary by type of
    [Show full text]
  • Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics
    December 6, 2000 NIDA-CTN-0007 MOTIVATIONAL INCENTIVES FOR ENHANCED DRUG ABUSE RECOVERY: METHADONE CLINICS Maxine Stitzer, Ph.D., Lead Investigator Nancy Petry, Ph.D. Co-Lead Investigator Robert Brooner, Ph.D. Co-Investigator Jessica Peirce, Project Coordinator Protocol work group: Nancy Petry New England Paul McLaughlin New England Richard Rawson Pacific Frank Flammino Pacific Bob Forman Delaware Valley Peter Barbur Northwest Sara Lamb Northwest Scott Kellogg New York Elaine Pencer New York Jack Blaine NIDA NIDA-CTN-0007 Motivational Incentives: Methadone Clinic 1 Version 6, Date December 6, 2000 December 6, 2000 TABLE OF CONTENTS 1 LIST OF ABBREVIATIONS................................................................................................. 3 2 PROTOCOL SUMMARY...................................................................................................... 4 3 BACKGROUND AND SIGNIFICANCE.............................................................................. 7 4 STUDY OBJECTIVE........................................................................................................... 10 5 SUSTAINABILITY WITHIN THE CTP’S ........................................................................ 10 6 STUDY DESIGN.................................................................................................................. 11 6.1 Drug targets....................................................................................................................... 11 6.2 Bonus incentive targets: opiates.......................................................................................
    [Show full text]
  • Collision of COVID-19 on Opioid Overdose and Treatment
    Emerging Issues in the Opioid Crisis Nora D. Volkow, M.D. Director National Institute on Drug Abuse @NIDAnews Overdose Deaths in 2019 Increased by 4.6% Number of Deaths Number of Deaths 40,000 Fentanyl, 37,137 18,000 Prescription opioids, 14,347 Methamphetamine, 16,539 35,000 16,000 Heroin, 14,278 Cocaine, 16,196 30,000 14,000 12,000 25,000 10,000 20,000 8,000 15,000 6,000 10,000 4,000 5,000 2,000 0 0 Overdose Death Rates: Other Synthetic Narcotics (Including Illicit Fentanyl) 2013 2018 Source: CDC WONDER. Age-adjusted death rates per 100,000. Overdose Death Rates: Psychostimulants With Abuse Potential (Including Methamphetamine) 2013 2018 Source: CDC WONDER. Age-adjusted death rates per 100,000. Intersection Between Opioid Crisis and COVID-19 ` Overdoses Grew Dramatically During COVID Pandemic ST Drug Use Increase During COVID Total US Increase 31.96% 19.96% 10.06% 12.52% 7 Millennium Health Signals Report™ COVID-19 Special Edition: Significant Changes in Drug Use During the Pandemic Volume 2.1 | Published July 2020 Total Study Population Change in Unadjusted Positivity Rate for Cocaine, Fentanyl, Heroin and Methamphetamine COVID-Related Policy Changes for Prescribing Medications for OUD Methadone Buprenorphine Prior to COVID: Prior to COVID: • Only federally-approved opioid • Prescribed through pharmacies in outpatient treatment programs settings • In-person for daily dosing • DATA 2000, limited to clinicians with bup. waivers that required additional training and Under COVID, SAMSHA allowed: federal registration • 3/16/2020: 28 day
    [Show full text]
  • Appendix 1 – Data Code Values
    Florida Department of Children and Families Substance Abuse and Mental Health Financial and Services Accountability Management System (FASAMS) Pamphlet 155-2 Appendix 1 Data Code Values Last Revision Date: 10/01/2021 Effective Date: 7/01/2021 Version 14.0 Pamphlet 155-2 Appendix 1, Version 14.0 Last Revision Date 10/01/2021 Effective Date: 7/01/2021 Page 1 of 64 Table of Contents 1 State/Province ................................................................................................................................................................ 3 2 County Area .................................................................................................................................................................... 4 3 Covered Service .............................................................................................................................................................. 5 4 Service Category ............................................................................................................................................................. 9 5 Project Codes .................................................................................................................................................................. 9 6 Project Codes, Method of Payment and Unit of Measure ........................................................................................... 13 7 FY 2021-22 Active OCA Codes ......................................................................................................................................
    [Show full text]
  • Minutes Health & Human Services Board Meeting
    MINUTES HEALTH & HUMAN SERVICES BOARD MEETING ROOM #1, OUTAGAMIE COUNTY ADMINISTRATION BUILDING TUESDAY, DECEMBER 13, 2016 MEMBERS PRESENT: Patrick Meyer, Vice-Chairperson; Dan Gabrielson, Secretary; *Justin Krueger; Richard Gosse; Jerry Iverson; Christine Lamers; Keith Suprise; and Cathy Thompson MEMBERS EXCUSED: Barney Lemanski, Chairperson; and Veronica Flower OTHERS PRESENT: Rosemary Davis, Director; John Rathman, Deputy Director; *Morgan Hinkley, Brewster Village Administrator; *Megan Vandehey, Brewster Village Student Intern; *Brad Dunlap, Department of Criminal Investigations, Narcotics Bureau; *Chris Wardlow, Substance Abuse Prevention Specialist; Mary Dorn, Public Health Officer/Manager; *Brian Bezier, Clinical Director/Manager of MH/AODA; and Linda Rasmussen, Management Assistant *Attended a portion of the meeting. Patrick Meyer called the meeting to order at 4:45 p.m. APPROVAL OF MINUTES: MOTION – Keith Suprise moved approval of the November 8, 2016 minutes. Seconded by Dan Gabrielson. (7 ayes, 0 nays, 1 abstention) Motion carried. PUBLIC COMMENT ON AGENDA ITEMS: None BREWSTER VILLAGE UPDATE AND TABLE OF ORGANIZATION CHANGE: Morgan Hinkley indicated that Brewster Village currently has 2 Administrative Secretaries sharing one full-time position, each working every other week. They are both retiring, which provided an opportunity to evaluate the structure of the position. Various back-up options were looked at, since the two functioned as each other’s back-ups. Additional staff were trained in various duties and discussion was held whether the position could be part time; however, in reviewing a time study and evaluating all of the tasks and how much time is spent on each of those, it was determined that there is a need for the position to be filled in a full-time capacity.
    [Show full text]